Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Short-term Investments: 2018-2025

Historic Short-term Investments for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Mar 2025 value amounting to $30,413.

  • China SXT Pharmaceuticals' Short-term Investments was N/A to $31,001 in Q3 2025 from the same period last year, while for Sep 2025 it was $31,001, marking a year-over-year change of. This contributed to the annual value of $30,413 for FY2025, which is 344.50% up from last year.
  • According to the latest figures from FY2025, China SXT Pharmaceuticals' Short-term Investments is $30,413, which was up 344.50% from $6,842 recorded in FY2024.
  • Over the past 5 years, China SXT Pharmaceuticals' Short-term Investments peaked at $45,297 during FY2022, and registered a low of $6,842 during FY2024.
  • Over the past 2 years, China SXT Pharmaceuticals' median Short-term Investments value was $18,628 (recorded in 2024), while the average stood at $18,628.
  • Data for China SXT Pharmaceuticals' Short-term Investments shows a peak YoY surged of 344.50% (in 2025) over the last 5 years.
  • Yearly analysis of 4 years shows China SXT Pharmaceuticals' Short-term Investments stood at $25,947 in 2021, then skyrocketed by 74.58% to $45,297 in 2022, then reached $6,842 in 2024, then spiked by 344.50% to $30,413 in 2025.